Fighting Addictions, Improving Lives: COmprehensive Drug Rehabilitation With Music

Summary

FALCO is a parallel pragmatic randomized control trial addressing long-term effects of music therapy (MT) on substance use disorder (SUD).

600 participants will be recruited from multiple European countries (see Locations). They will be randomized into one of the following intervention arms: Active Music Group (AMG), Music Listening Group (MLG) or Treatment as Usual (TAU) as offered locally.

Conditions

• Substance Use Disorder (SUD)

Interventions

BEHAVIORAL

Active Music Group (AMG)

Active music group is a music therapy intervention where participants actively make/play music in groups. The sessions will be conducted by an appropriately qualified music therapist.

BEHAVIORAL

Music Listening Group (MLG)

Music listening group is a music therapy intervention where participants partake in music listening in groups. The sessions will be conducted by an appropriately qualified music therapist.

BEHAVIORAL

Treatment as Usual (TAU)

Treatment as usual as provided locally, which may include pharmacological and/or non-pharmacological interventions (e.g. mindfulness-based intervention, structured physical activity).

Sponsors & Collaborators

• University of Bergen

  collaborator OTHER

• Helse Stavanger HF

  collaborator OTHER_GOV

• Sykehuset Innlandet HF

  collaborator OTHER

• University of Vienna

  collaborator OTHER

• Anton Proksch Institut

  collaborator UNKNOWN

• University of Music and Performing Arts, Vienna

  collaborator UNKNOWN

• Austrian Institute for Health Technology Assessment GmbH

  collaborator UNKNOWN

• Herzog College

  collaborator UNKNOWN

• Bar-Ilan University, Israel

  collaborator OTHER

• University of Pavia

  collaborator OTHER

• University of Gdańsk

  collaborator UNKNOWN

• Wojewódzki Ośrodek Terapii Uzależnień w Gdańsku

  collaborator UNKNOWN

• Institut d'Investigació Biomèdica de Bellvitge

  collaborator OTHER

• Institució Catalana de Recerca i Estudis Avançats

  collaborator UNKNOWN

• Universitat de Girona

  collaborator OTHER

• Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta

  collaborator OTHER

• Fundació Sanitària d'Igualada

  collaborator UNKNOWN

• University of Zurich

  collaborator OTHER

• NORCE Norwegian Research Centre AS

  lead OTHER

Principal Investigators

• Christian Gold, PhD · NORCE Research Centre

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2025-07-01

Primary Completion

2028-06-30

Completion

2037-06-30

Countries

• Austria
• Israel
• Italy
• Norway
• Palestinian Territories
• Poland
• Spain
• Switzerland

Study Locations